HOME >> BIOLOGY >> NEWS
Early clinical treatment can halt progression of Alzheimer's disease, UCI researchers find

Irvine, Calif. -- UC Irvine neurobiologists have provided the first evidence that early clinical treatment of brain lesions can halt the progression of Alzheimer's disease.

Working on genetically modified mice, the researchers found that using specific antibodies to clear a certain type of brain lesion reversed abnormalities arising from a second type of brain lesion, which halted the progression of the disease. Researchers also found that the earlier the treatment begins, the better the chances of success findings that have similar implications for people, emphasizing the need for better means of early diagnosis and treatment of patients with Alzheimer's disease.

The findings are reported in the Aug. 5 issue of Neuron.

"Current estimates indicate that by the middle of the century, 20 million Americans will suffer from Alzheimer's disease," said Frank LaFerla, associate professor of neurobiology and behavior and head of the research team. "Our results have direct implications for the clinical treatment of this insidious disease."

Alzheimer's is a progressive disease and the most common cause of dementia among the elderly in the United States, affecting 4.5-5 million adults — 10 times more than those affected by Parkinson's disease. The disease is marked by the accumulation of two distinct brain lesions — beta-amyloid plaques and neurofibrillary tangles. Both plaques and tangles accumulate in specific brain regions critical to learning and memory.

It is believed that their accumulation contributes to the destruction of brain cells and the eventual loss of memory. The belief among many neuroscientists that the accumulation of amyloid plaques is the initiating trigger of the disease process constitutes the "amyloid cascade hypothesis" a controversial theory in neuroscience. By showing that the progression of Alzheimer's can be stopped by early treatment of the plaques, the new findings strongly support the h
'"/>

Contact: Iqbal Pittalwala
iqbal@uci.edu
949-824-3969
University of California - Irvine
4-Aug-2004


Page: 1 2 3

Related biology news :

1. Berkeley Lab soil scientist Margaret Torn receives Presidential Early Career Award
2. Early detection hope for eye disease
3. Early dexamethasone exposure has long-term neurodevelopment, neuroendocrine effects
4. Early predictor of breast cancer aggressiveness
5. Early treatment confirmed as key to stroke recovery
6. Early identification of kidney disease cost-effective only when directed at high-risk patients
7. Early promise for treatment of Ebola
8. Early treatment can prevent severe vision loss in premature infants
9. Early hominids may have behaved more human than we had thought
10. Early infection and rejection detection
11. Early-life environments shape development of stress behaviors and learning abilities in mice

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... -- The Allen Institute for Cell Science today announces the ... and dynamic digital window into the human cell. The ... of deep learning to create predictive models of cell ... growing suite of powerful tools. The Allen Cell Explorer ... available resources created and shared by the Allen Institute ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)... March 29, 2017  higi, the health IT company ... North America , today announced a Series ... acquisition of EveryMove. The new investment and acquisition accelerates ... tools to transform population health activities through the collection ... higi collects and secures data today on ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... compared the implantation and pregnancy rates in frozen and fresh in vitro ... of progesterone and maternal age to IVF success. , After comparing the results ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive global ... technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, ...
(Date:10/10/2017)... 2017 International research firm Parks Associates announced today ... the TMA 2017 Annual Meeting , October 11 in ... home security market and how smart safety and security products impact the ... Parks Associates: Smart Home Devices: ... "The residential security market has experienced ...
(Date:10/10/2017)... ... October 10, 2017 , ... The Pittcon Program Committee ... honoring scientists who have made outstanding contributions to analytical chemistry and applied ... the world’s leading conference and exposition for laboratory science, which will be held ...
Breaking Biology Technology:
Cached News: